Skip to content
Evigrade
MajorAntiviral for systemic use, HIV-1 protease inhibitor; used only with a pharmacokinetic booster (ritonavir or cobicistat)×Phosphodiesterase type 5 inhibitors (PDE5)

Updated · Methodology

Mechanism

The liver clears sildenafil mainly through CYP3A4 and to a lesser extent through CYP2C9, so inhibitors of these enzymes can slow its clearance (sildenafil summary of product characteristics, SmPC, European Medicines Agency, EMA). Darunavir is taken only with a booster (ritonavir or cobicistat), and the boosted regimen inhibits CYP3A (darunavir SmPC, EMA). In a study, a single 25 mg dose of sildenafil taken with darunavir and low-dose ritonavir gave systemic sildenafil exposure comparable to a single 100 mg dose taken alone (darunavir SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The cobicistat-boosted regimen has not been studied, but sildenafil levels are expected to rise with it too because of CYP3A inhibition (darunavir/cobicistat SmPC, EMA). The US sildenafil label notes that other human immunodeficiency virus (HIV) protease inhibitors have not been studied with sildenafil but are expected to raise its levels (sildenafil label, US Food and Drug Administration, FDA).

Symptoms

Higher sildenafil levels can make its adverse effects more frequent: visual disturbances, low blood pressure, prolonged erection and fainting (darunavir summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). An erection lasting more than 4 hours needs urgent medical care. If priapism is not treated at once, it can damage penile tissue and cause permanent loss of potency (sildenafil SmPC, European Medicines Agency, EMA). In healthy volunteers, a 200 mg dose did not improve efficacy but caused more headache, flushing, dizziness, dyspepsia, nasal congestion and visual disturbances (sildenafil SmPC, EMA).

Management

In pulmonary arterial hypertension the combination is contraindicated. Sildenafil for this indication is on the contraindication list of darunavir boosted with either ritonavir or cobicistat, because no safe and effective sildenafil dose has been established with this regimen (darunavir and darunavir/cobicistat summaries of product characteristics, SmPCs, European Medicines Agency, EMA, and Spanish Agency of Medicines and Medical Devices, AEMPS; darunavir labels, US Food and Drug Administration, FDA). Sildenafil for pulmonary hypertension is itself contraindicated with the most potent CYP3A4 inhibitors, with ritonavir given as an example (sildenafil SmPC for pulmonary hypertension, EMA). For erectile dysfunction, sildenafil with darunavir needs caution. Give a single dose of no more than 25 mg in 48 hours (darunavir and darunavir/cobicistat SmPCs, EMA and AEMPS) and monitor more closely for sildenafil adverse effects (darunavir FDA labels). When darunavir is boosted with ritonavir, sildenafil for erectile dysfunction is not advised with ritonavir (sildenafil SmPC, EMA). In this case the sildenafil dose must never exceed 25 mg in 48 hours (sildenafil SmPC, EMA). The US limit is the same (sildenafil FDA label). Warn the patient that an erection lasting more than 4 hours needs urgent care. If a sudden visual disturbance appears, stop sildenafil (sildenafil SmPC, EMA). Before starting darunavir, also read the prescribing information of the booster, whether ritonavir or cobicistat (darunavir SmPC, EMA).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Darunavir

Other interactions with Sildenafil